Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FGFR Inhibition in Urothelial Carcinoma.
Li R, Linscott J, Catto JWF, Daneshmand S, Faltas BM, Kamat AM, Meeks JJ, Necchi A, Pradere B, Ross JS, van der Heijden MS, van Rhijn BWG, Loriot Y. Li R, et al. Among authors: van rhijn bwg. Eur Urol. 2024 Sep 30:S0302-2838(24)02605-8. doi: 10.1016/j.eururo.2024.09.012. Online ahead of print. Eur Urol. 2024. PMID: 39353825 Review.
The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder Cancer.
Beijert IJ, Hagberg O, Gårdmark T, Holmberg L, Häggström C, Johnston A, Trail M, Hamid S, Dreyer BA, Padovani L, Garau R, Hasan R, Ahmad I, Hendry D, Compérat EM, Burger M, Rouprêt M, Gontero P, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, Mariappan P, Liedberg F, van Rhijn BWG; BladderBaSe-Consortium; Scot BC Quality OPS Collaborative; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973; WHO2004/2016 Classification Systems for Grade. Beijert IJ, et al. Among authors: van rhijn bwg. Eur Urol. 2024 Aug 28:S0302-2838(24)02528-4. doi: 10.1016/j.eururo.2024.08.013. Online ahead of print. Eur Urol. 2024. PMID: 39209674 Free article.
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update.
Gontero P, Birtle A, Capoun O, Compérat E, Dominguez-Escrig JL, Liedberg F, Mariappan P, Masson-Lecomte A, Mostafid HA, Pradere B, Rai BP, van Rhijn BWG, Seisen T, Shariat SF, Soria F, Soukup V, Wood R, Xylinas EN. Gontero P, et al. Among authors: van rhijn bwg. Eur Urol. 2024 Aug 17:S0302-2838(24)02514-4. doi: 10.1016/j.eururo.2024.07.027. Online ahead of print. Eur Urol. 2024. PMID: 39155194 Review.
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy.
van Gennep EJ, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, Eckstein M, Mertens LS, Bussani R, Burger M, Boormans JL, Wullich B, Hartmann A, Mayr R, Pavan N, Bartoletti R, Mir MC, Pouessel D, van der Hoeven J, van der Kwast TH, Allory Y, Zuiverloon TCM, Lotan Y, van Rhijn BWG. van Gennep EJ, et al. Among authors: van rhijn bwg. Bladder Cancer. 2024 Jun 18;10(2):119-132. doi: 10.3233/BLC-230086. eCollection 2024. Bladder Cancer. 2024. PMID: 39131875 Free PMC article.
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature.
Claps F, Biasatti A, Di Gianfrancesco L, Ongaro L, Giannarini G, Pavan N, Amodeo A, Simonato A, Crestani A, Cimadamore A, Hurle R, Mertens LS, van Rhijn BWG, Porreca A. Claps F, et al. Among authors: van rhijn bwg. J Clin Med. 2024 Jul 25;13(15):4349. doi: 10.3390/jcm13154349. J Clin Med. 2024. PMID: 39124615 Free PMC article. Review.
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.
Chelushkin MA, van Dorp J, van Wilpe S, Seignette IM, Mellema JJ, Alkemade M, Gil-Jimenez A, Peters D, Brugman W, Stockem CF, Hooijberg E, Broeks A, van Rhijn BWG, Mertens LS, van der Heijden AG, Mehra N, van Montfoort ML, Wessels LFA, Vis DJ, van der Heijden MS. Chelushkin MA, et al. Among authors: van rhijn bwg. Clin Cancer Res. 2024 Sep 13;30(18):4227-4239. doi: 10.1158/1078-0432.CCR-24-0724. Clin Cancer Res. 2024. PMID: 39047168
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels.
Mertens LS, Bruins HM, Contieri R, Babjuk M, Rai BP, Puig AC, Escrig JLD, Gontero P, van der Heijden AG, Liedberg F, Martini A, Masson-Lecomte A, Meijer RP, Mostafid H, Neuzillet Y, Pradere B, Redlef J, van Rhijn BWG, Rouanne M, Rouprêt M, Sæbjørnsen S, Seisen T, Shariat SF, Soria F, Soukup V, Thalmann G, Xylinas E, Mariappan P, Alfred Witjes J. Mertens LS, et al. Among authors: van rhijn bwg. Eur Urol Oncol. 2024 Jun 20:S2588-9311(24)00141-X. doi: 10.1016/j.euo.2024.05.010. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38906795
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature Review.
Contieri R, Pichler R, Del Giudice F, Marcq G, Gallioli A, Albisinni S, Soria F, d'Andrea D, Krajewski W, Carrion DM, Mari A, van Rhijn BWG, Moschini M, Pradere B, Mertens LS; EAU Young Academic Urologists Urothelial Cancer Working Group. Contieri R, et al. Among authors: van rhijn bwg. J Clin Med. 2024 Apr 30;13(9):2637. doi: 10.3390/jcm13092637. J Clin Med. 2024. PMID: 38731165 Free PMC article.
206 results